PROJECT 4: VULNERABILITY TO WHITE MATTER PROGRESSION IN SCHIZOPHRENIA

项目 4:精神分裂症患者白质进展的脆弱性

基本信息

项目摘要

Recent MRI studies demonstrate progressive changes in gray matter in temporal and frontal cortices following onset of schizophrenia. Far less, however, is known about white matter abnormalities, particularly fronto-temporal connections, long thought to be abnormal in schizophrenia. Additionally, post-mortem studies indicate that astrocytes and oligodendrocytes may be abnormal. Since glial cells play an important role in neuronal migration and in synaptic function, their dysfunction could lead to reduced neuronal size, reduced levels of synaptic proteins, as well as to abnormalities in neurotransmission and functional dysconnectivity. Of further note, recent genetic studies point to oligodendrocyte and myelin related (OMR) abnormalities. Taken together, these findings indicate that an investigation of white matter may lead to a further understanding of the neuropathology of schizophrenia. The main aim of this project is to investigate evidence for vulnerability to progression of white matter abnormalities in schizophrenia, at various stages of the illness (i.e., before, at first onset, long after illness onset), in order to delineate possible putative markers. Subjects will be: (1) 75 prodrome at risk subjects at study entry and at 1-year follow-up, and for those who convert to a first episode of schizophrenia, also at time of entry into the first episode study; (2) 80 first episode schizophrenia, defined by first hospitalization, at study entry.and followed at 6-mths and 18-mths; (3) 42 patients diagnosed with chronic schizophrenia. Normal controls will be group matched for age, gender, etc., to each cohort. We will use Diffusion Tensor Imaging to evaluate fronto-temporal white matter fiber connections (uncinate fasciculus, cingulate bundle, arcuate fasciculus, and fornix), corpus callosum, anterior commissure, and anterior limb of internal capsule, where we predict decreased anisotropy in chronic schizophrenics>first episode with changes at 18 months>first episode changes at 6 months>prodromes who convert>prodromes who do not convert. We also predict associations with OMR genes, where we will test for association between gene sequence variants (single nucleotide polymorphisms-SNPs) for six OMR genes (NRG1, ErbBS, MAG, CNP, MOG, GRM3). (See also Postmortem Core for isolation of mRNA from 4 OMR genes-ErbB3, MAG, CNP, MOG). This proposal will provide new discoveries relevant to white matter progression in schizophrenia, which will likely lead to new treatment and preventative strategies.
最近的核磁共振研究显示颞叶和额叶皮质的灰质进行性改变。 在精神分裂症发作后。然而,对白质异常的了解要少得多,尤其是 额颞部连接,长期以来被认为在精神分裂症中是不正常的。此外,尸检 研究表明,星形胶质细胞和少突胶质细胞可能是异常的。因为神经胶质细胞扮演着重要的角色 在神经元迁移和突触功能中的作用,它们的功能障碍可能导致神经元体积缩小, 突触蛋白水平降低以及神经传递和功能异常 连接障碍。更值得注意的是,最近的遗传学研究指出少突胶质细胞和髓鞘相关(OMR) 异常现象。综上所述,这些发现表明,对白质的调查可能导致 对精神分裂症神经病理学的进一步认识。这个项目的主要目的是调查 精神分裂症不同阶段白质异常进展易感性的证据 疾病(即发病之前、发病后很久),以便描述可能的推定标志物。 研究对象为:(1)75名有前驱症状的高危受试者,在研究开始时和一年随访时,以及 转换为精神分裂症的第一个发作,也是在进入第一个发作研究的时候;(2)80个首先 发病精神分裂症,以首次住院定义,在研究开始时,在6个月和18个月后;(3) 42例诊断为慢性精神分裂症患者。正常对照组将在年龄、性别、 等等,到每个队列。我们将使用扩散张量成像来评估额颞白质纤维 联系(钩状束、扣带束、弓状束和穹隆)、胼胝体、前部 连合和内囊前肢,我们预测慢性病患者的各向异性降低 精神分裂症患者的首发症状在18个月后发生变化,首发症状在6个月时发生变化 转换&>;不转换的前身。我们还预测了与OMR基因的关联,我们将在那里进行测试 用于6个OMR的基因序列变异(单核苷酸多态-SNPs)之间的关联 基因(NRG1、ERBBS、MAG、CNP、MOG、GRM3)。(另请参阅死后核心以从4个细胞中分离出mRNA OMR基因-ErbB3、MAG、CNP、MOG)。这项提议将提供与白质相关的新发现。 精神分裂症的进展,这可能会导致新的治疗和预防策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Martha E. Shenton其他文献

Negative symptoms, cognition, and community functioning in early psychosis
早期精神病中的阴性症状、认知和社会功能
  • DOI:
    10.1016/j.schres.2025.05.015
  • 发表时间:
    2025-07-01
  • 期刊:
  • 影响因子:
    3.500
  • 作者:
    Julia Blotner;Rachel Hechinger;Martha E. Shenton;Michael J. Coleman;Dost Öngür;Kathryn E. Lewandowski
  • 通讯作者:
    Kathryn E. Lewandowski
552. Parsing the Heterogeneity of White Matter Microstructure and Cognition in Psychosis Spectrum Disorders
552. 解析精神病谱系障碍中白质微观结构和认知的异质性
  • DOI:
    10.1016/j.biopsych.2025.02.791
  • 发表时间:
    2025-05-01
  • 期刊:
  • 影响因子:
    9.000
  • 作者:
    Brendan Stiltner;Sinead Kelly;Suheyla Cetin-Karayumak;Rebekah Trotti;Victor Zeng;Sarah K. Keedy;Elliot S. Gershon;Godfrey Pearlson;Brett A. Clementz;Jennifer E. McDowell;Scot K. Hill;Carol A. Tamminga;Ofer Pasternak;Martha E. Shenton;Matcheri S. Keshavan;Paulo Lizano
  • 通讯作者:
    Paulo Lizano
420 - The MRI study of cavum septi pellucidi in schizophrenia and affecfive disorder
  • DOI:
    10.1016/s0920-9964(97)82428-0
  • 发表时间:
    1997-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Jun Soo Kwon;Martha E. Shenton;Yoshio Hirayasu;Iris A. Fischer;Robert W. McCarley
  • 通讯作者:
    Robert W. McCarley
676 - Temporal P300 asymmetry in schizophrenia vs. Manic psychosis and controls
  • DOI:
    10.1016/s0920-9964(97)82684-9
  • 发表时间:
    1997-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Dean F. Salisbury;Iris A. Fischer;Martha E. Shenton;Andrea R. Sherwood;Paola Mazzoni;Robert W. McCarley
  • 通讯作者:
    Robert W. McCarley
THALAMO-FRONTAL WHITE MATTER FIBER TRACTS IN SCHIZOPHRENIA-DIFFUSION STOCHASTIC TRACTOGRAPHY STUDY
  • DOI:
    10.1016/s0920-9964(08)70248-2
  • 发表时间:
    2008-06-01
  • 期刊:
  • 影响因子:
  • 作者:
    Marek Kubicki;Martha E. Shenton;Tri Ngo;Gudrun Rosenberger;Carl-Fredrik Westin;James J. Levitt;Robert W. McCarley
  • 通讯作者:
    Robert W. McCarley

Martha E. Shenton的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Martha E. Shenton', 18)}}的其他基金

Development of MR Biomarkers of Brain Injury in Acute and Chronic mTBI
急性和慢性 mTBI 脑损伤 MR 生物标志物的开发
  • 批准号:
    9017823
  • 财政年份:
    2014
  • 资助金额:
    $ 49.9万
  • 项目类别:
Development of MR Biomarkers of Brain Injury in Acute and Chronic mTBI
急性和慢性 mTBI 脑损伤 MR 生物标志物的开发
  • 批准号:
    9392487
  • 财政年份:
    2014
  • 资助金额:
    $ 49.9万
  • 项目类别:
Development of MR Biomarkers of Brain Injury in Acute and Chronic mTBI
急性和慢性 mTBI 脑损伤 MR 生物标志物的开发
  • 批准号:
    8675403
  • 财政年份:
    2014
  • 资助金额:
    $ 49.9万
  • 项目类别:
PROJECT 4: VULNERABILITY TO WHITE MATTER PROGRESSION IN SCHIZOPHRENIA
项目 4:精神分裂症患者白质进展的脆弱性
  • 批准号:
    8136029
  • 财政年份:
    2010
  • 资助金额:
    $ 49.9万
  • 项目类别:
CORE 3: IMAGING
核心 3:成像
  • 批准号:
    8136032
  • 财政年份:
    2010
  • 资助金额:
    $ 49.9万
  • 项目类别:
MR Brain Diffusion Tensor Imaging in Schizophrenia
精神分裂症的 MR 脑扩散张量成像
  • 批准号:
    8195956
  • 财政年份:
    2009
  • 资助金额:
    $ 49.9万
  • 项目类别:
MR Brain Diffusion Tensor Imaging in Schizophrenia
精神分裂症的 MR 脑扩散张量成像
  • 批准号:
    8586852
  • 财政年份:
    2009
  • 资助金额:
    $ 49.9万
  • 项目类别:
MR Brain Diffusion Tensor Imaging in Schizophrenia
精神分裂症的 MR 脑扩散张量成像
  • 批准号:
    7906939
  • 财政年份:
    2009
  • 资助金额:
    $ 49.9万
  • 项目类别:
MR Brain Diffusion Tensor Imaging in Schizophrenia
精神分裂症的 MR 脑扩散张量成像
  • 批准号:
    7796311
  • 财政年份:
    2009
  • 资助金额:
    $ 49.9万
  • 项目类别:
MR Brain Diffusion Tensor Imaging in Schizophrenia
精神分裂症的 MR 脑扩散张量成像
  • 批准号:
    8390428
  • 财政年份:
    2009
  • 资助金额:
    $ 49.9万
  • 项目类别:

相似海外基金

Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
  • 批准号:
    495182
  • 财政年份:
    2023
  • 资助金额:
    $ 49.9万
  • 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
  • 批准号:
    2601817
  • 财政年份:
    2021
  • 资助金额:
    $ 49.9万
  • 项目类别:
    Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
  • 批准号:
    2029039
  • 财政年份:
    2020
  • 资助金额:
    $ 49.9万
  • 项目类别:
    Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
  • 批准号:
    9888417
  • 财政年份:
    2019
  • 资助金额:
    $ 49.9万
  • 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
  • 批准号:
    17K11318
  • 财政年份:
    2017
  • 资助金额:
    $ 49.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    10166936
  • 财政年份:
    2017
  • 资助金额:
    $ 49.9万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9320090
  • 财政年份:
    2017
  • 资助金额:
    $ 49.9万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9761593
  • 财政年份:
    2017
  • 资助金额:
    $ 49.9万
  • 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
  • 批准号:
    BB/M50306X/1
  • 财政年份:
    2014
  • 资助金额:
    $ 49.9万
  • 项目类别:
    Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
  • 批准号:
    288272
  • 财政年份:
    2013
  • 资助金额:
    $ 49.9万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了